Vizsgálati helyszín
Scottsdale Clinical Trials
Scottsdale, Arizona 85260, Egyesült ÁllamokMég nincs intézményhez kötve
- 13futó vizsgálat
- 8lezárt vizsgálat
Az itteni vizsgálatok
Miről szól a helyszín 21 vizsgálata, a regiszteri adatlapjaik szerint.
- Fázis
- 3. fázis17 vizsgálat
- 2. fázis3 vizsgálat
- Állapot
- Lezárult7 vizsgálat
- Toboroz7 vizsgálat
- Fut, nem toboroz6 vizsgálat
- Leállították1 vizsgálat
- Fő szponzor
- Eli Lilly and Company3 vizsgálat
- Vertex Pharmaceuticals Incorporated3 vizsgálat
- Alumis Inc2 vizsgálat
- ModernaTX, Inc.2 vizsgálat
- Viridian Therapeutics, Inc.2 vizsgálat
- és még 9
Futó vizsgálatok
Toboroz
Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation
NCT07626411· 3. fázis· Regeneron Pharmaceuticals· Forrás
Contact: Clinical Trials Administrator
Toboroz
A Study to Assess NAV-240 in Adult Participants With Hidradenitis Suppurativa
NCT07384975· 2. fázis· Navigator Medicines, Inc.· Forrás
Contact: Associate Director, Clinical Operations
Toboroz
Study of DONQ52 in Active Celiac Disease
NCT07239336· 2. fázis· Chugai Pharmaceutical· Forrás
Toboroz
Evaluation of Efficacy and Safety of Suzetrigine (SUZ) for Pain Associated With Diabetic Peripheral Neuropathy
NCT07231419· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
NCT07116967· 3. fázis· Bristol-Myers Squibb· Forrás
Contact: Todd Dreitzler, Site 0432
Fut, nem toboroz
Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis
NCT06846541· 3. fázis· Alumis Inc· Forrás
Fut, nem toboroz
Evaluation of the Long-term Safety and Effectiveness of Suzetrigine (SUZ) in Participants With Painful Diabetic Peripheral Neuropathy (DPN)
NCT06696443· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Toboroz
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy
NCT06628908· 3. fázis· Vertex Pharmaceuticals Incorporated· Forrás
Fut, nem toboroz
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)
NCT06625398· 3. fázis· Viridian Therapeutics, Inc.· Forrás
Fut, nem toboroz
An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)
NCT06625411· 3. fázis· Viridian Therapeutics, Inc.· Forrás
Fut, nem toboroz
Cadisegliatin as Adjunctive Therapy to Insulin in Participants With Type 1 Diabetes
NCT06334133· 3. fázis· vTv Therapeutics· Forrás
Fut, nem toboroz
The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)
NCT06383390· 3. fázis· Eli Lilly and Company· Forrás
Toboroz
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
NCT06112418· Cleerly, Inc.· Forrás
Contact: Todd Dreitzler, MD
Egyszerre toboroz
Hány vizsgálat toboroz itt egyszerre ugyanarra az indikációra. Darabszám, nem értékelés.
Lezárt vizsgálatok
Lezárult
Ixekizumab Concomitantly Administered With Tirzepatide in Adults With Moderate-to-Severe Plaque Psoriasis and Obesity or Overweight
NCT06588283· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis
NCT06586112· 3. fázis· Alumis Inc· Forrás
Lezárult
Effect of Retatrutide Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With Diet and Exercise Alone (TRANSCEND-T2D-1)
NCT06354660· 3. fázis· Eli Lilly and Company· Forrás
Lezárult
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.
NCT06178991· 3. fázis· BioNTech SE· Forrás
Lezárult
A Study of mRNA-1083 (SARS-CoV-2 and Influenza) Vaccine in Healthy Adult Participants, ≥50 Years of Age
NCT06097273· 3. fázis· ModernaTX, Inc.· Forrás
Leállították
Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria
NCT06077773· 2. fázis· Escient Pharmaceuticals, Inc· Forrás
Lezárult
A Study to Evaluate the Safety and Immune Response of mRNA-1345, a Vaccine Targeting Respiratory Syncytial Virus (RSV), When Co-administered With a Fluzone HD, in Adults ≥65 Years of Age
NCT06060457· 3. fázis· ModernaTX, Inc.· Forrás
Lezárult
A Study Assessing Rocatinlimab on Vaccine Antibody Response in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET - VOYAGER)
NCT05899816· 3. fázis· Amgen· Forrás
Hibát jelzek